Imatinib resistance and blast transformation of chronic myeloid leukemia associated with a novel tri-nucleotide insertion mutation of BCR-ABL kinase domain at position K294
Document Type
Article
Publication Date
1-1-2012
Abstract
A letter to the editor is presented which discusses the introduction of imatinib mesylate (IM) in the medical case of an 18-year old man with in-frame mutations and blast transformation of chronic myeloid leukemia (CML).
Keywords
Imatinib, Chronic myeloid leukemia
Divisions
fac_med
Publication Title
Annals of Hematology
Volume
91
Issue
1
Publisher
Springer Verlag (Germany)
COinS